Zhengye Biotechnology Holding Limited (ZYBT:NASDAQ) closed at $1.45 on October 19, 2026, up 3.57% on the day. The stock trades 81.9% below its 52-week high of $8.01 and 135.4% above its 52-week low of $0.616. Over the past year, it lost 45.1%. Zhengye Biotechnology Holding Limited is part of the Health Care sector.
In 251 trading sessions since October 17, 2025, ZYBT closed higher on 86 days (34%). Its best day was August 5, 2026 (+84.38%) and its worst was July 21, 2026 (-64.42%). The stock moved 10% or more in a single session 28 times. It opened at least 5% above the previous day's high 1 time.
Zhengye Biotechnology Holding, through its operating entity, focus on the research, development, manufacturing and sales of veterinary vaccines, with an emphasis on vaccines for livestock. For nearly 20 years, the operating entity has been committed to enhancing the health of livestock by offering a diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs. The operating entity's products are available in 29 provincial regions across China and are exported overseas, to Vietnam, Pakistan, and Egypt.
Find more stocks like ZYBT with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.